Optimal medical treatment versus endovascular aortic repair in uncomplicated isolated abdominal aortic dissection

医学 四分位间距 外科 主动脉夹层 回顾性队列研究 单变量分析 解剖(医学) 主动脉修补术 病历 腹部外科 动脉瘤 内科学 主动脉 多元分析
作者
Sheng Su,Jitao Liu,Changjin Wang,Rui-Rong Chen,Yuanli Liu,Wenhui Huang,Songyuan Luo,Fan Yang,Jianfang Luo
出处
期刊:Journal of Vascular Surgery [Elsevier]
卷期号:77 (4): 1028-1036.e2
标识
DOI:10.1016/j.jvs.2022.10.036
摘要

To report the results of optimal medical treatment (OMT) and endovascular aortic repair (EVAR) in patients with uncomplicated isolated abdominal aortic dissection (IAAD).A retrospective review of 96 consecutive patients with uncomplicated IAAD (uIAAD) managed at a single tertiary vascular unit between January 2011 and July 2021 was conducted. Standard methods for univariate and survival analyses were used. The primary outcomes were all-cause mortality. Secondary end points included uIAAD progression, interventional complications, and follow-up aortic intervention.Initially, 53.1% of patients (51/96) were managed with OMT. No in-hospital deaths occurred. During follow-up, three patients died, and three and two patients who were initially managed with OMT subsequently required endovascular treatment and surgical management, respectively. Initially, 46.9% of patients (45/96) underwent EVAR. One patient died during hospital admission; nine patients had an endoleak after operation and one needed reintervention. Furthermore, during follow-up, five patients died; four patients needed reoperation, one surgery and three endovascular treatments. The overall long-term mortality was 8.4%, and follow-up aortic intervention rate was 9.5% (median follow-up, 54 months; interquartile range, 33-81 months) with no significant difference between groups. Of note, 12 patients (12.6%) suffered uIAAD progression, which was higher in the OMT group than EVAR group (10 [19.6%] vs 2 [4.5%]; P = .03).uIAAD may be managed safely by OMT with regular surveillance, despite the risk of disease progression. Compared with OMT, EVAR could significantly prevent uIAAD progression. For anatomically suitable patients with uIAAD progression and who are unresponsive to OMT, pre-emptive EVAR is a safe and feasible option.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
背后的雪卉应助冥土采纳,获得10
1秒前
1秒前
zho应助琳666采纳,获得10
2秒前
3秒前
Zr完成签到,获得积分10
3秒前
科研通AI6应助科研通管家采纳,获得10
3秒前
子车茗应助科研通管家采纳,获得10
3秒前
3秒前
浮游应助科研通管家采纳,获得10
3秒前
BowieHuang应助科研通管家采纳,获得10
3秒前
在水一方应助科研通管家采纳,获得10
3秒前
bkagyin应助科研通管家采纳,获得10
3秒前
浮游应助科研通管家采纳,获得10
3秒前
无极微光应助科研通管家采纳,获得20
3秒前
科研通AI6应助科研通管家采纳,获得10
3秒前
维奈克拉应助科研通管家采纳,获得10
3秒前
子车茗应助科研通管家采纳,获得100
3秒前
NexusExplorer应助科研通管家采纳,获得10
4秒前
搜集达人应助科研通管家采纳,获得10
4秒前
4秒前
子车茗应助科研通管家采纳,获得100
4秒前
4秒前
深情安青应助科研通管家采纳,获得10
4秒前
浮游应助科研通管家采纳,获得10
4秒前
英姑应助科研通管家采纳,获得10
4秒前
Akim应助科研通管家采纳,获得30
4秒前
维奈克拉应助科研通管家采纳,获得10
4秒前
4秒前
浮游应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
4秒前
4秒前
南小木完成签到,获得积分20
5秒前
6秒前
上官若男应助Nell采纳,获得10
6秒前
zilhua发布了新的文献求助10
8秒前
Ava应助ZZZ采纳,获得10
8秒前
顾矜应助小L采纳,获得10
8秒前
li完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
List of 1,091 Public Pension Profiles by Region 1621
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] | NHBS Field Guides & Natural History 1500
The Victim–Offender Overlap During the Global Pandemic: A Comparative Study Across Western and Non-Western Countries 1000
King Tyrant 720
T/CIET 1631—2025《构网型柔性直流输电技术应用指南》 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5588835
求助须知:如何正确求助?哪些是违规求助? 4671698
关于积分的说明 14789060
捐赠科研通 4626566
什么是DOI,文献DOI怎么找? 2531974
邀请新用户注册赠送积分活动 1500561
关于科研通互助平台的介绍 1468343